ExpSup: Obese Diabetic Patients Have Higher Levels of Phosphoenolpyruvate Carboxykinase (PEPCK) in Liver

The following studies have analyzed phosphoenolpyruvate carboxykinase (PEPCK) expression in the liver of obese diabetic and obese nondiabetic Individuals. For more details and accuracy, please read the recommended references carefully.

  • Bhalla and coworkers analyzed the microarray data set of livers from obese diabetic and obese nondiabetic Individuals. They observed higher levels of PEPCK in the liver of obese diabetic individuals compared to obese non-diabetic individuals (Bhalla et al., 2014). 
    • Experimental details:
      • Microarray data set generated by Pihlajamäki and coworkers (Pihlajamäki et al., 2009)
      • Organism: obese diabetic individuals than in obese nondiabetic humans

REFERENCES:

Was this post helpful?

Author: admin

Leave a Reply

Your email address will not be published. Required fields are marked *